1685 Branham Lane, Suite 227, San Jose, CA 95118 - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

1685 Branham Lane, Suite 227, San Jose, CA 95118

Description:

Second Wind Lung Transplant Association. The Anne Harroun Landgraf Foundation ... Pulmonary Fibrosis Association (1996-2003) American Lung Association(s) ... – PowerPoint PPT presentation

Number of Views:37
Avg rating:3.0/5.0
Slides: 15
Provided by: markas2
Category:

less

Transcript and Presenter's Notes

Title: 1685 Branham Lane, Suite 227, San Jose, CA 95118


1
1685 Branham Lane, Suite 227, San Jose, CA
95118 888.222.8541 info_at_coalitionforpf.org
2
Unifying Nonprofit Efforts
  • Mary D. Harris Memorial Foundation
  • The Pulmonary Paper
  • Caring Voice Coalition
  • AARDA/NCAPG
  • Second Wind Lung Transplant Association
  • The Anne Harroun Landgraf Foundation
  • The Fred J. Brotherton Charitable Foundation
  • Pulmonary Fibrosis Association (1996-2003)
  • American Lung Association(s)
  • 30 medical and research institutions nationwide
  • The need for IPF education and awareness
    initiatives for patients and healthcare
    professionals has never been greater. Marvin
    Schwarz, MD, CPF Chair

3
CPF Objectives
  • Unify nonprofit education and advocacy efforts to
    help those patients and families fighting PF
  • Improve detection, diagnosis and treatment of PF
    in clinical community
  • Encourage, support and fund emerging research to
    ultimately lead to a cure

4
Services Remain in High Demand
  • Free Resource Kit for IPF patients and families,
    including all ed. materials
  • Comprehensive Website for patients and medical
    professionals www.coalitionforpf.org
  • 34 Support Groups Nationwide
  • Living With IPF Seminars
  • Mentoring, counseling, program referrals,
    transplant education support
  • Toll-free number - 888-222-8541

5
Research and Professional Education
  • Detection and diagnosis Mon. (2002)
  • American Journal of Nursing Mon. (2002)
  • Basic Research Questionnaire (2003-2005) -Submitt
    ing for publication 6/05
  • IPF Treatment Guidelines Monograph
    (2004) -Submitted for publication 4/05
  • 60,000 Research Grant to University of Michigan
    2/05
  • Role of Circulating fibrocytes TGF-b
    downregulation
  • Financial support to UMinn, Duke, UCLA
  • Public Opinion Survey (Fall, 2005)

6
CPF Basic Research Questionnaire
  • Established in October 2003 by private restricted
    grant
  • Advance awareness of IPF issues
  • Strengthen CPF programs and advocacy efforts
  • Identify patient and professional education needs
  • Advance research efforts to find a cure for IPF

7
Interim Results (First 1,000 Responses)
  • DIAGNOSTIC INFORMATION
  • 15 of patients with IPF had not had their
    diagnosis confirmed by HRCT or surgical lung
    biopsy. ATS C.S. on IPF states either test, or
    both, are recommended to make a conclusive
    diagnosis
  • 44 of patients diagnosed with IPF within one
    year of having symptoms of IPF, however 18 were
    accurately diagnosed with IPF more than one year
    after the onset of symptoms, 16 after more than
    two years, and 12 after more than 5 years

8
Interim Results (Cont.)
  • 55 of respondents indicated that they were
    initially misdiagnosed with another respiratory
    or pulmonary condition before being accurately
    diagnosed with IPF.
  • Of this subset of respondents, 17 were initially
    misdiagnosed with Bronchitis, 13 with an
    unspecified respiratory ailment, 12 with Asthma,
    7 with COPD, and 6 with Emphysema

9
Interim Results (Cont.)
  • POTENTIAL CAUSES OF IPF
  • 14 of respondents indicated also being diagnosed
    with rheumatoid arthritis 53 GERD
  • 67 of respondents indicated that they had smoked
    cigarettes the median length of time smoking was
    22 years, and the median time of smoking
    cessation was 19 years before their IPF diagnosis

10
Interim Results (Cont.)
  • 22 of respondents indicated exposure to
    asbestos, 21 to molds 13 heavy use of
    pesticides
  • 11 at least one other family member with IPF
  • Among current patients, 30 of responded that
    their physician has not discussed or even
    mentioned the topic of lung transplantation of
    those under the age of 60, only 24 have been
    advised to register for a transplant

11
You Can Help Advance IPF Issues
  • Help raise awareness for IPF among
    policymakers in your state and in Washington,
    D.C.
  • Urge members of Congress to support funding for
    IPF education and research efforts
  • Monitor and respond to legislation that impacts
    the IPF community
  • Support your local medical centers!

12
What Do We Accomplish?
  • Targets
  • -U.S. Congress (Senate House)
  • -Federal Agencies (DHHS, NIH, NHLBI, CMS)
  • -State Government (Governors Office, State
    Health Commissioner, State senate House)
  • -State Health Agencies (Insurance Comm.,
    Medicare Administrator)

13
2005 Activities
  • National IPF Awareness Week 9/25-10/1
  • Ending the Medicare 24 Month Waiting Period Act
    of 2005
  • Function 550 Increases Finances public health
    services, including NIH, DHHS, CDC CPF and more
    than 250 groups advocating
  • Stem Cell Research Enhancement Act of 2005 HR
    810 Expands the number of stem cells available
    for research support of 200 in Congress

14
CPF Contact Information
  • Web www.coalitionforpf.org
  • Email info_at_coalitionforpf.org
  • Phone 888.222.8541
  • Address

1685 Branham LaneSuite 227San Jose, CA 95118
Write a Comment
User Comments (0)
About PowerShow.com